Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

NCT04618198 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04618198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04618198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
Lead sponsor
University of Virginia
Phase
Phase 3
Overall status
Completed
Start date
January 5, 2022
Completion date
May 20, 2025
Enrollment
437 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv i infection, sepsis, tuberculosis